title: Protection of perfused lung from oxidant injury by inhibitors of anion exchange.
abstract: Hyperoxic lung injury is enhanced in isolated perfused lungs (IPL) in the presence of L-arginine. Reactive O2 species such as superoxide anion (O2-.) produced during hyperoxia are known to react with nitric oxide to form the strong oxidant species peroxynitrite. The appearance of O2-. in red blood cell membranes in vitro and in buffer-perfused lung preparations can be inhibited by the stilbene compound 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS) DIDS also inhibits anion exchange across the cell membrane regulated by a family of anion exchange proteins (AE). In this study, we hypothesized that anion exchange inhibitors would prevent lung injury from hyperoxia and L-arginine (O2 + L-Arg) by decreasing O2-. flux into the vascular space of the IPL. We found that both DIDS and a structurally distinct anion transport blocker, dipyridamole, protected the rabbit IPL from pulmonary hypertension and edema produced by O2 + L-Arg. The protective effect was associated with increased nitrite concentrations in the perfusate. Protection also was conferred when sodium bicarbonate in the perfusion buffer was replaced with either sodium thiosulfate or N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES). In lungs perfused with thiosulfate or HEPES-containing buffer, protection from O2 and L-arginine was also associated with diminished detection of reducing activity consistent with O2-. in the vascular space. Western blot analysis of lung protein and immunocytochemical staining of lung sections using antibodies against rabbit red blood cell AE1 and mouse gastric AE2 peptide showed that lung contains membrane protein antigenically similar to gastric AE2. These data suggest the possibility that inhibition of AE or other anion transporters may play an important role in mediating oxidative lung injury.
authors.affiliation: Department of Pediatrics, Duke University Medical Center, Durham, North Carolina 27710, USA.
authors.forename: E
authors.initials: E
authors.lastname: Nozik-Grayck
authors.forename: C A
authors.initials: CA
authors.lastname: Piantadosi
authors.forename: J
authors.initials: J
authors.lastname: van Adelsberg
authors.forename: S L
authors.initials: SL
authors.lastname: Alper
authors.forename: Y C
authors.initials: YC
authors.lastname: Huang
mesh_terms: D017878:4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid / Q000494:pharmacology; D000818:Animals; D017920:Antiporters / Q000037:antagonists & inhibitors*; D001120:Arginine / Q000494:pharmacology; D015153:Blotting, Western; D002021:Buffers; D004176:Dipyridamole / Q000494:pharmacology; D005110:Extracellular Space / Q000378:metabolism; D006976:Hypertension, Pulmonary / Q000139:chemically induced / Q000517:prevention & control; D007150:Immunohistochemistry; D066298:In Vitro Techniques; D008168:Lung / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D009573:Nitrites / Q000378:metabolism; D016877:Oxidants / Q000494:pharmacology*; D010100:Oxygen / Q000494:pharmacology; D010477:Perfusion; D011654:Pulmonary Edema / Q000139:chemically induced / Q000517:prevention & control; D011817:Rabbits; D013481:Superoxides / Q000378:metabolism
chemical_list: D017920:Antiporters; D002021:Buffers; D009573:Nitrites; D016877:Oxidants; D013481:Superoxides; D004176:Dipyridamole; D001120:Arginine; D017878:4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; D010100:Oxygen